Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: Results of randomised double-blind controlled studies

Journal of Hypertension

Volumn 16, Issue 11, 1998, Pages 1677-1684

  Ambrosioni, Ettore ^a   Safar, Michel ^b   Degaute, Jean Paul ^c   Malin, Pier Luigi ^a   MacMahon, Mark ^d   Rodriguez Pujol, Diego ^e   De Cordoüe, Agnès ^f   Guez, David ^f,g  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HÔPITAL BROUSSAIS   (France)

^c ERASME HOSPITAL   (Belgium)

^d WEXHAM PARK HOSPITAL   (United Kingdom)

^e UNIVERSITY OF ALCALÁ   (Spain)

^f INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^g IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

Clinical trials; Equivalence study; Hypertension; Indapamide; Long term study; Low dose diuretic

Indexed keywords

INDAPAMIDE; POTASSIUM ION;

ADULT; AGED; ANGINA PECTORIS; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASTHENIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; GOUT; GYNECOMASTIA; HEADACHE; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POLYURIA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SUSTAINED RELEASE PREPARATION; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; VERTIGO; XEROSTOMIA;

EID: 0031794783     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816110-00015     Document Type: Article

References (27)

1. The sixth report of the Joint National Committee on Prevention, Detection. Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157:2413-2446.
2. 1993 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1993; 22:392-403.
3. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reduction in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-838.
4. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug-treatment in older persons with isolated systolic hypertension. JAMA 1991; 265:3255-3264.
5. MRC Working Party Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-412.
6. Leonetti G, Rappelli A, Salvetti A, Scapellato L. Long-term effects of indapamide: final results of a 2-year Italian multicenter study in systemic hypertension. Am J Cardiol 1990; 65:67H-71H.
7. Chaffman M, Heel RC, Brodgen RN, Speight TM, Avery GS. Indapamide: a review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs 1988; 28:121-249.
8. Senior R, lmbs JL, Bory M, Amabile G, Denis B, Zannad F, et al. Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study. J Cardiovasc Pharmacol 1993; 22:106-110.
9. Carey PA, Sheridan DJ, de Cordoüe A, Guez D. Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis. Am J Cardiol 1996; 77:17B-19B.
10. Ames RP. A comparison of blood lipid and blood pressure responses during treatment of systemic hypertension with indapamide and with thiazides. Am J Cardiol 1996; 77:12B-16B.
11. Leonetti G, Rappelli A, Saloetti A, Scapellato L. Tolerability and well-being with indapamide in the treatment of mild-moderate hypertension. Am J Med 1988; 84 (suppl 1B):59-64.
12. Guez D, Mallion JM, Degaute JP, Malini PL, Baldwin R, Rodriguez-Pujol D et al. Traitement de l'hypertension artérielle par indapamide 1,5 mg, comprimé enrobé à libération prolongée: synthėse des résultats. Arch Mal Coeur Vaiss 1996; 89:17-25.
13. Mallion JM, Asmar R, Ambriosioni E, MacMahon M, Coupez JM, de Courdoüe A, et al. Evaluation du rapport vallée/pic de l'indapamide 1,5 mg comprimé enrobé à libération prolongée par la mesure ambulatoire de la pression artérielle. Arch Mal Coeur Vaiss 1996; 89:27-38.
14. Schuirmann DJ. A comparison of the two one-sided tests procedures and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987; 15:657-680.
15. Fernandes M, Martinez E, Fiorentmi R, Mazzella J, Affrine M. The antihypertensive effect of indapamide in low doses. Curr Med Res Opin 1977; 5:60-63.
16. Hashida JC. A double-blind multicentre study of indapamide in the treatment of essential hypertension. Curr Med Res Opin 1977; 5:116-123.
17. 7 Schlesinger P, Oignam W, Fadel Tabet F, Burlamaqui A. The treatment of hypertension with indapamide: a controlled trial. Curr Med Res Opin 1977; 5:159-164.
18. Capone P, Vukovich RA, Neiss S. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension. Clin Ther 1983; 5:305-316.
19. Hall WD, Weber MA, Ferdinand K, Flamenbaum W, Marbury T, Jain AK, et al. Lower dose diuretic therapy in the treatment of patients with mild-to-moderate hypertension. J Hum Hypertens 1994; 8:571-575.
20. Fiddes R, Blumenthal J, Dawson JE, Dyckman E, St John-Hammond PG, Harris S, et al. Evaluation of indapamide 1.25 mg once daily in elderly patients with mild-to-moderate hypertension. J Hum Hypertens 1997; 11:239-244.
21. St John-Hammond PG, Ratner P, Mullican W, Littlejohn T, Plieskow W, Kaihlanen M, et al. Dose-response study of indapamide [abstract]. J Am Soc Nephrol 1993; 4:541.
22. Brunner HR, Mėnard J, Waeber B, Burnier M, Biollaz J, Nussberger J, et al. Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations. J Hypertens 1990; 8:3-11.
23. Kaplan NM, Alderman MH, Flamenbaum W, McCarron DA, Perry HM, Saunders E, et al. Guidelines for the treatment of hypertension. Am J Hypertens 1989, 2:75-77.
24. Chalmers J, Wing L, Taylor S. Analysis of time trends, individual subject responses and background variation in crossover factorial studies with antihypertensive drugs. J Hypertens 1990; 8 (suppl 4):S27-S35.
25. Mallion JM, Asmar R, Boutelant S. Twenty-four-hour antihypertensive efficacy of indapamide 1.5 mg sustained release: results of two randomized double-blind controlled studies. J Cardiovasc Pharmacol 1998; 32:673-678.
26. Knochel JP. Diuretic-induced hypokalemia. Am J Med 1984; 11:18-27.
27. Morgan DB, Davidson C, Hypokalemia and diuretics: an analysis of publications. BMJ 1980; 280:905-908.